AOD-9604 & CJC-1295 & Ipamorelin
A targeted fat loss stack combining AOD-9604 (the fat-burning fragment of HGH) with CJC-1295 and Ipamorelin for comprehensive body recomposition. This blend addresses fat loss directly while supporting lean mass through GH optimization.
Mechanism of Action
AOD-9604 stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or blood glucose. CJC-1295 and Ipamorelin provide sustained and pulsatile GH release to support metabolism and lean tissue. The combination targets fat loss through multiple mechanisms while preserving muscle.
Typical Dosage (Research)
Typical protocol: AOD-9604 200-400mcg, CJC-1295 100-200mcg, Ipamorelin 100-200mcg daily. Usually administered in the morning fasted or before exercise.
Subcutaneous injection. Best administered fasted to maximize fat-burning effects. Can be taken as a pre-mixed blend or separate injections. Cycles typically run 8-16 weeks.
Side Effects & Risks
Mild injection site reactions, headache, nausea. Generally well-tolerated as AOD-9604 lacks many HGH side effects.
AOD-9604 is not FDA approved and is banned by WADA. Limited clinical evidence for the combination. Results depend heavily on diet and exercise.
Who Uses AOD-9604 & CJC-1295 & Ipamorelin
Those focused on fat loss and body recomposition, individuals seeking to reduce stubborn fat while maintaining or building lean mass, fitness enthusiasts during cutting phases.